Results 61 to 70 of about 1,187,227 (316)

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Active Q-switching in semiconductor ring lasers

open access: yes, 2008
We report on the integration of semiconductor ring lasers with tunable directional couplers to modulate the Q-factor of the ring cavity.
S. Furst   +5 more
core   +1 more source

Topological Insulator: $\hbox{Bi}_{2}\hbox{Te}_{3}$ Saturable Absorber for the Passive Q-Switching Operation of an in-Band Pumped 1645-nm Er:YAG Ceramic Laser

open access: yesIEEE Photonics Journal, 2013
An in-band pumped 1.645-μm Er:YAG ceramic laser passively Q-switched by a topological insulator: Bi2Te3 saturable absorber is reported. The average output power could reach up to 210 mW, corresponding to a pulsewidth, a pulse repetition rate, and ...
Pinghua Tang   +8 more
doaj   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

Q-switched induced gain switching of a twotransition cascade laser [PDF]

open access: yes, 2012
A gain-switched laser transition, of a two-laser-transition cascade laser, that is driven by the adjacent laser transition which is Q-switched is demonstrated using a Ho3+ -doped fluoride fiber laser. Q-switching the 5|6 ?
Li, Jianfeng   +2 more
core   +1 more source

Long‐Term Neurologic Exam Findings in People Diagnosed and Treated During Acute HIV Infection

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Evaluate clinical and laboratory correlates of abnormal neurologic exam findings after acute HIV infection (AHI). Methods Participants from the RV254/SEARCH 010 cohort in Bangkok underwent standardized neurologic examinations at Weeks 0 (AHI), 12, 96, and 288 following antiretroviral therapy (ART).
Kathryn B. Holroyd   +118 more
wiley   +1 more source

"Optical code label switching and its applications, invited paper at Photonics in Switching, Herakleion Greece, 2006

open access: yes, 2006
With current mature optical device technology for processing optical codes (OCs), OC label switchings now become promising for the future photonic networkings.
CINCOTTI, GABRIELLA   +4 more
core  

Whispering gallery modes in semiconductor optical fibres and optical bottle microresonators

open access: yes
We explore the optical properties of whispering gallery modes (WGMs) in silicon optical fibres and optical bottle microresonators. In particular, a pump-probe technique is used to experimentally demonstrate thermally induced all-optical modulation.
Horak, P.   +5 more
core   +1 more source

LncRNA Subcellular Localization Across Diverse Cell Lines: An Exploration Using Deep Learning with Inexact q-mers

open access: yesNon-Coding RNA
Background: Long non-coding Ribonucleic Acids (lncRNAs) can be localized to different cellular compartments, such as the nuclear and the cytoplasmic regions.
Weijun Yi   +3 more
doaj   +1 more source

Sex Differences in Medication Discontinuation in Axial Spondyloarthritis

open access: yesArthritis Care &Research, EarlyView.
Objective We examined sex differences in medication discontinuation among patients with axial spondyloarthritis (axSpA) initiating tumor necrosis factor inhibitors (TNFi), interleukin‐17 inhibitors (IL‐17i), or JAK inhibitors (JAKi). Methods Using data from the Rheumatology Informatics System for Effectiveness (RISE) Registry (2003–2025), we assessed ...
Rachael Stovall   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy